Trial RPCEC00000346
Publication Hernandez-Bernal , EClinicalMedicine, 2022
Primary outcome on the report: Seroconversion day 56, define as at least a four-fold increase of antibody titers over baseline.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.